Icelandic Biotech Firm ArcanaBio Wins International Life Science Award

Icelandic biotech firm ArcanaBio has achieved a significant international recognition, winning the annual "Nordic Accelerator Life Science 2026" competition held in New York. This marks the first time an Icelandic startup has claimed victory in the prestigious contest, which features promising life and health technology companies from across the Nordic region.

During the competition, ArcanaBio showcased its groundbreaking technology designed to empower individuals in analyzing and tracking vital health-related proteins. Utilizing advanced diagnostic devices that employ novel light technology and artificial intelligence, the system can process samples such as saliva. This innovation promises a more accessible approach to personal health monitoring.

“

new technology that will enable individuals to analyze and monitor important health-related proteins, including from saliva, with a diagnostic device that uses new light technology and artificial intelligence that ArcanaBio has been working on in recent years.

Further bolstering its achievements, ArcanaBio recently obtained a patent in the United States for its core technology. The company states that this patented system aims to enable general health measurements to be conducted conveniently at home. Through AI-powered analysis, individuals will be able to monitor their long-term health status, offering a proactive approach to well-being.

As a result of winning the competition, ArcanaBio received valuable prizes, including office and meeting space in New York City for one year. Additionally, the company gains access to the networking opportunities and advisory services provided by the Swedish-American Chamber of Commerce, facilitating its growth and market penetration.

“

general health measurements at home possible, where it will be possible to monitor long-term health with the help of artificial intelligence.